Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma

Nature Immunology

Volumn 16, Issue 12, 2015, Pages 1235-1244

  Finkin, Shlomi ^a,b   Yuan, Detian ^c   Stein, Ilan ^a,b   Taniguchi, Koji ^d   Weber, Achim ^e   Unger, Kristian ^f   Browning, Jeffrey L ^g   Goossens, Nicolas ^h,i   Nakagawa, Shigeki ^h   Gunasekaran, Ganesh ^h   Schwartz, Myron E ^h   Kobayashi, Masahiro ^j   Kumada, Hiromitsu ^j   Berger, Michael ^a   Pappo, Orit ^b   Rajewsky, Klaus ^k   Hoshida, Yujin ^h   Karin, Michael ^d   Heikenwalder, Mathias ^c,l   Ben Neriah, Yinon ^a   Pikarsky, Eli ^a,b   more..

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^j TORANOMON HOSPITAL   (Japan)

^k MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^l GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA; CYTOKINE; I KAPPA B KINASE; TRANSCRIPTOME;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECTOPIC LYMPHOID LIKE STRUCTURE; GENE ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; INNATE IMMUNITY; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LYMPHOID TISSUE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL NICHE; T CELL DEPLETION; ANIMAL; C57BL MOUSE; CANCER STEM CELL; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE MODEL; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; LIVER CELL; LIVER TUMOR; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADAPTIVE IMMUNITY; ANIMALS; CARCINOMA, HEPATOCELLULAR; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOKINES; DISEASE MODELS, ANIMAL; HEPATOCYTES; HUMANS; I-KAPPA B KINASE; IMMUNITY, INNATE; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; LYMPHOID TISSUE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASTIC STEM CELLS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL NICHE; T-LYMPHOCYTES; TRANSCRIPTOME;

EID: 84947863720     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3290     Document Type: Article

References (50)

1. Coppola, D., et al. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am. J. Pathol. 179, 37-45 (2011
2. Pitzalis, C., Jones, G.W., Bombardieri, M., & Jones, S.A. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat. Rev. Immunol. 14, 447-462 (2014
3. Di Caro, G., et al. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clin. Cancer Res. 20, 2147-2158 (2014
4. Dieu-Nosjean, M.C., et al. Long-Term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. Journal of clinical oncol. 2008, 26(27) 4410-4417
5. Gu-Trantien, C., et al. CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J. Clin. Invest. 123, 2873-2892 (2013
6. Messina, J.L., et al. 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Sci. Rep. 2, 765 (2012
7. Di Caro, G., & Marchesi, F. Tertiary lymphoid tissue: A gateway for T cells in the tumor microenvironment. OncoImmunology 3, e28850 (2014
8. Torrecilla, S., & Llovet, J.M. New molecular therapies for hepatocellular carcinoma. Clin. Res. Hepatol. Gastroenterol. 39, S80-S85 (2015
9. El-Serag, H.B. Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118-1127 (2011
10. Umemura, A., et al. Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. Cell Metab. 20, 133-144 (2014
11. Scheuer, P.J., Ashrafzadeh, P., Sherlock, S., Brown, D., & Dusheiko, G.M The pathology of hepatitis C. Hepatology 15, 567-571 (1992
12. Gerber, M.A. Histopathology of HCV infection. Clin. Liver Dis. 1, 529-541 (1997
13. Hoshida, Y., et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N. Engl. J. Med. 359, 1995-2004 (2008
14. Murakami, J., et al Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C. Hepatology 30, 143-150 (1999
15. Hoshida, Y., Villanueva, A., & Llovet, J.M. Molecular profiling to predict hepatocellular carcinoma outcome. Expert Rev. Gastroenterol. Hepatol. 3, 101-103 (2009
16. Drayton, D.L., Liao, S., Mounzer, R.H., & Ruddle, N.H. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7, 344-353 (2006
17. Sasaki, Y., et al. Canonical NF-?B activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24, 729-739 (2006
18. Postic, C., & Magnuson, M.A. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26, 149-150 (2000
19. Pikarsky, E., et al. NF-kappaB functions as a tumour promoter in inflammation-Associated cancer. Nature 431, 461-466 (2004
20. Cairo, S., et al. Hepatic stem-like phenotype and interplay of Wnt/β-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14, 471-484 (2008
21. He, G., et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155, 384-396 (2013
22. Wada, Y., Nakashima, O., Kutami, R., Yamamoto, O., & Kojiro, M. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27, 407-414 (1998
23. Schneider, C., et al. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. Gut 61, 1733-1743 (2012
24. Okin, D., & Medzhitov, R. Evolution of inflammatory diseases. Curr. Biol. 22, R733-R740 (2012
25. Karin, M., Lawrence, T., & Nizet, V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124, 823-835 (2006
26. Haybaeck, J., et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 16, 295-308 (2009
27. Wolf, M.J., Seleznik, G.M., & Heikenwalder, M. Lymphotoxin's link to carcinogenesis: friend or foe? from lymphoid neogenesis to hepatocellular carcinoma and prostate cancer. Adv. Exp. Med. Biol. 691, 231-249 (2011
28. Tumanov, A.V., et al. T cell-derived lymphotoxin regulates liver regeneration. Gastroenterology 136, 694-704 (2009
29. Drutskaya, M.S., Efimov, G.A., Kruglov, A.A., Kuprash, D.V., & Nedospasov, S.A. Tumor necrosis factor, lymphotoxin and cancer. IUBMB Life 62, 283-289 (2010
30. Bauer, J., et al. Lymphotoxin, NF-kB, and cancer: the dark side of cytokines. Dig. Dis. 30, 453-468 (2012
31. Yun, C., et al. NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. Cancer Lett. 184, 97-104 (2002
32. Yu, G.Y., et al. Hepatic expression of HCV RNA-dependent RNA polymerase triggers innate immune signaling and cytokine production. Mol. Cell 48, 313-321 (2012
33. Arzumanyan, A., Reis, H.M., & Feitelson, M.A. Pathogenic mechanisms in HBV-And HCV-Associated hepatocellular carcinoma. Nat. Rev. Cancer 13, 123-135 (2013
34. Mosnier, J.F., et al. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology 17, 366-371 (1993
35. Qi, H., Kastenmuller, W., & Germain, R.N. Spatiotemporal basis of innate and adaptive immunity in secondary lymphoid tissue. Annu. Rev. Cell Dev. Biol. 30, 141-167 (2014
36. Iwasaki, A., & Medzhitov, R. Regulation of adaptive immunity by the innate immune system. Science 327, 291-295 (2010
37. Verna, L., Whysner, J., & Williams, G.M. N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-Adduct formation, mutagenicity, and tumor initiation. Pharmacol. Ther. 71, 57-81 (1996
38. Yau, T.O., et al. Hepatocyte-specific activation of NF-?B does not aggravate chemical hepatocarcinogenesis in transgenic mice. J. Pathol. 217, 353-361 (2009
39. Subramanian, A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005
40. Hoshida, Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS ONE 5, e15543 (2010
41. Bruix, J., & Sherman, M. American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update. Hepatology 53, 1020-1022 (2011
42. Tian, B., Nowak, D.E., Jamaluddin, M., Wang, S., & Brasier, A.R. Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling. J. Biol. Chem. 280, 17435-17448 (2005
43. Hinata, K., Gervin, A.M., Jennifer Zhang, Y., & Khavari, P.A. Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin. Oncogene 22, 1955-1964 (2003
44. Delhase, M., Hayakawa, M., Chen, Y., & Karin, M. Positive and negative regulation of I?B kinase activity through IKKbeta subunit phosphorylation. Science 284, 309-313 (1999
45. Saito, M., et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 19, 746-750 (2001
46. Huang, L.R., et al. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infection. Nat. Immunol. 14, 574-583 (2013
47. van de Wiel, M.A., et al. CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics 23, 892-894 (2007
48. Venkatraman, E.S., & Olshen, A.B. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23, 657-663 (2007
49. van de Wiel, M.A., & Wieringen, W.N. CGHregions: dimension reduction for array CGH data with minimal information loss. Cancer Inform. 3, 55-63 (2007
50. Hindson, B.J., et al. High-Throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem. 83, 8604-8610 (2011